Industry mutes doctors

Share this article:

Drugmakers are paying less to get doctors talking, reports ProPublica, which has found the the industry has slashed the amount of money it spends on speakers' fees.

As examples, the nonprofit notes that Eli Lilly spent 55% less on speakers in 2012 than it did in 2011, Pfizer spent 62% less and Novartis whittled its speaker spend by 40%. In terms of numbers, this comes down to Lilly spending $21.6 million in 2012, compared to $47.9 million three years ago, while Pfizer dropped only $8.3 million on speakers in 2012, compared to $22 million in 2011.

ProPublica notes that not all companies have reduced their spend and that some companies attributed their reduced speakers' budgets to lack of pipeline excitement as opposed to fear of Sunshine Act disclosures.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters